Page 155 - SPONDYLOARTHRITIS IN COLOMBIA -

References
1 Van den Berg R, de Hooge M, van Gaalen F (2013) Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology 2:1492–9
2 Sepriano A, Rubio R, Ramiro S, et al. Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis. Ann Rheum Dis 2017;76:886-890
3 Carneiro S, Bortoluzzo AB, Gonçalves CR et al. Effect of enthesitis on 1505 Brazilian patients with spondyloarthritis. J Rheumatol 2013;40:1719–25
4 Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995;7:263–9
5 Navarro-Compán V, de Miguel E, van der Heijde D et al. Sponyloarthritis features forecasting the presence of HLA- B27 or sacroiliitis on magnetic resonance imaging in patients with suspected axial spondyloarthritis: results from a
cross-sectional study in the ESPeranza Cohort. Arthritis Res Ther 2015; 17: 265-271
6 Vossen MH, den Broeder AA, Hendriks-Roelofs F, et al. Improvement in deployment of MRI of the sacroiliac joints
in patients suspected for spondyloarthritis using a targeted intervention: a case study. Rheumatology (Oxford)
2013;52:933-8
7 Moltó A, Etcheto A, van der Heijde D, et al. Prevalence of comorbidities and evaluation of their screening in
spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis. 2015 Oct 21. pii: annrheumdis-2015-208174
9 Haroon NN, Paterson JM, Inman RD, et al. Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality A Population-Based Study. Ann Intern Med 2015;163:409-16
10 Bakland G, Gran JT, Nossent JC. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 2011;70:1921-5
11 Cisneros JR, Murray KM. Corticosteroids in tuberculosis. Ann Pharmacother 1996;30: 1298–303
12 Keane J. Tumor necrosis factor blockers and reactivation of latent tuberculosis. Clin Infect Dis 2004;39:300–302
13 de Pablo, P, Chapple IL, Buckley CD, et al. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol
2009;5:218–224
14 van Gaalen F, Ioan-Facsinay A, Huizinga TW, Toes RE. The devil in the details: the emerging role of anticitrulline
autoimmunity in rheumatoid arthritis. J Immunol 2005;175:5575–5580
15 Kiltz U, van der Heijde D, Boonen A, et al. The ASAS Health Index (ASAS HI) - a new tool to assess the health status
of patients with spondyloarthritis. Clin Exp Rheumatol 2014;32:S-105-8
16 Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-
report measures. Spine. 2000;25:3186-91
17 Cardiel MH, Londoño JD, Gutiérrez E, et al. Translation, cross-cultural adaptation, and validation of the Bath
Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 2003;21:451-8
18 Ariza-Ariza R, Hernández-Cruz B, Navarro-Sarabia F. Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis Rheum 2003;49:483-7
19 Kirkham JJ, Boers M, Tugwell P et al. Outcome measures in rheumatoid arthritis randomised trials over the last 50 years. Trials 2013;14:324
20 van der Heijde D, Bellamy N, Calin A et al. Preliminary core sets for endpoints in ankylosing spondylitis. J Rheumatol 1997;24:2225–9
8 Han C, Robinson DW, Hackett MV, et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006;33:2167-72
153